Abstract
The analysis of pleural fluid (PF) is the most important diagnostic element in identifying the cause of pleural effusions. The measurement of proteins and lactate dehydrogenase in PF and blood establishes the transudative or exudative nature of effusions. Elevated concentrations of natriuretic peptide NT-proBNP (>1500 pg/mL) are virtually pathognomonic of heart failure. In exudates with predominantly polymorphonuclear leukocytes (>50%), a bacterial infection of the pleural space should be considered, particularly if pleural fluid C-reactive protein levels are high. A pleural pH <7.20 in a parapneumonic effusion is an indication for the need of a drainage tube. When lymphocytes predominate in an exudate, cancer and tuberculosis are the two main diagnoses to consider; an adenosine deaminase activity >35 U/L strongly supports the diagnosis of tuberculosis. The cytological study of PF is negative in 40% of malignant effusions. Performing immunocytochemistry on the cell block and measuring tumor markers, such as mesothelin, can increase the diagnostic yield for malignancy.
Keywords: Empyema, malignant pleural effusion, pleural effusion, tuberculous pleuritis, tumor markers.
Current Respiratory Medicine Reviews
Title:The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice
Volume: 8 Issue: 5
Author(s): Jose M. Porcel
Affiliation:
Keywords: Empyema, malignant pleural effusion, pleural effusion, tuberculous pleuritis, tumor markers.
Abstract: The analysis of pleural fluid (PF) is the most important diagnostic element in identifying the cause of pleural effusions. The measurement of proteins and lactate dehydrogenase in PF and blood establishes the transudative or exudative nature of effusions. Elevated concentrations of natriuretic peptide NT-proBNP (>1500 pg/mL) are virtually pathognomonic of heart failure. In exudates with predominantly polymorphonuclear leukocytes (>50%), a bacterial infection of the pleural space should be considered, particularly if pleural fluid C-reactive protein levels are high. A pleural pH <7.20 in a parapneumonic effusion is an indication for the need of a drainage tube. When lymphocytes predominate in an exudate, cancer and tuberculosis are the two main diagnoses to consider; an adenosine deaminase activity >35 U/L strongly supports the diagnosis of tuberculosis. The cytological study of PF is negative in 40% of malignant effusions. Performing immunocytochemistry on the cell block and measuring tumor markers, such as mesothelin, can increase the diagnostic yield for malignancy.
Export Options
About this article
Cite this article as:
Porcel M. Jose, The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice, Current Respiratory Medicine Reviews 2012; 8 (5) . https://dx.doi.org/10.2174/157339812803832485
DOI https://dx.doi.org/10.2174/157339812803832485 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Selective Matrix Metalloproteinase Inhibitors for Cancer
Current Medicinal Chemistry Biomaterial and Mesenchymal Stem Cell for Articular Cartilage Reconstruction
Current Stem Cell Research & Therapy Diagnostic Value of Chest X-Ray in Febrile Patients without Localizing Signs or Symptoms at the Emergency Department
Current Medical Imaging Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Anti-Cancer Agents in Medicinal Chemistry Cellular and Molecular Pathways that Lead to Progression and Regression of Renal Fibrogenesis
Current Molecular Medicine Acyclonucleosides, Modified Seco-Nucleosides, and Salicyl- or Catechol- Derived Acyclic 5-Fluorouracil O,N-Acetals: Antiproliferative Activities, Cellular Differentiation and Apoptosis
Current Medicinal Chemistry Analytical Methods for the Determination of Anti-diuretic Peptides in Biological Samples: Challenges and Perspectives
Current Analytical Chemistry Good at Heart: Preserving Cardiac Metabolism during aging
Current Diabetes Reviews The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune Disorders
Current Rheumatology Reviews The Thyroid-cardiac Axis: Thyroid Function, Cardiac Rhythmology, and Sudden Cardiac Death
Endocrine, Metabolic & Immune Disorders - Drug Targets Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders
Current Drug Targets Extended-release Formulation Attenuates the Impacts of Fluvastatin on Serum PCSK9 Levels in Humans
Letters in Drug Design & Discovery Circulating Endothelial Progenitor Cells as Biomarkers for Prediction of Cardiovascular Outcomes
Current Medicinal Chemistry Gene Patents in the Primary Prevention of Vascular Diseases
Recent Patents on DNA & Gene Sequences Oxidative Stress and Transforming Growth Factor-β<sub>1</sub>-induced Cardiac Fibrosis
Cardiovascular & Hematological Disorders-Drug Targets Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Sedation and Analgesia in Pediatric Intensive Care
Current Drug Targets Therapeutic Potential for Thyroid Hormone Receptor-β Selective Agonists for Treating Obesity, Hyperlipidemia and Diabetes
Current Vascular Pharmacology Effects of Evolocumab on Cardiovascular Events
Current Cardiology Reviews